ResMed Inc. (ASX: RMD)
Australia
· Delayed Price · Currency is AUD
37.00
-0.83 (-2.19%)
Nov 7, 2024, 4:10 PM AEST
ResMed Revenue
ResMed had revenue of $1.22B USD in the quarter ending September 30, 2024, with 11.08% growth. This brings the company's revenue in the last twelve months to $4.81B, up 9.88% year-over-year. In the fiscal year ending June 30, 2024, ResMed had annual revenue of $4.69B with 10.95% growth.
Revenue (ttm)
$4.81B
Revenue Growth
+9.88%
P/S Ratio
n/a
Revenue / Employee
$481.71K
Employees
9,980
Market Cap
54.87B AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
Jun 30, 2020 | 2.96B | 350.44M | 13.44% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 22.18B |
Fisher & Paykel Healthcare Corporation Limited | 1.60B |
Pro Medicus Limited | 161.50M |
Cochlear Limited | 2.24B |
Sonic Healthcare Limited | 8.97B |
Ramsay Health Care Limited | 16.66B |
Telix Pharmaceuticals Limited | 645.68M |
Clarity Pharmaceuticals Ltd | 11.51M |
ResMed News
- 1 day ago - ResMed Announces Participation in the UBS Global Healthcare Conference - GlobeNewsWire
- 3 days ago - My Top 15 High-Growth Dividend Stocks For November 2024 - Seeking Alpha
- 9 days ago - P/E Ratio Insights for ResMed - Benzinga
- 13 days ago - Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst - Benzinga
- 13 days ago - Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst - Benzinga
- 13 days ago - ResMed declares $0.53 dividend - Seeking Alpha
- 13 days ago - ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - ResMed rises 5% on Q3 beats - Seeking Alpha